Pregnant women with type 1 diabetes who used both real-time continuous glucose monitoring and capillary glucose monitoring improved their time-in-range and were able to reach A1C goals set by the American Diabetes Association from their first trimester until 34 weeks gestation, compared with those who only used capillary glucose monitoring, according to a study in Diabetes Technology & Therapeutics. However, the researchers noted that improvements in terms of “better pre-pregnancy planning, lifestyle changes, as well as treatment and technological advances" are needed for pregnant women with type 1 diabetes to achieve the tight CGM time-in-range and ADA A1C targets before late gestation.
Full Story: Healio (free registration)/Endocrine Today (6/2)